Efficacy of two doses of external counterpulsation (ECP) on glycemic control in people with type 2 diabetes mellitus: A randomized SHAM-controlled trial
Primary result · Change in HbA1cResult — go to the resultMean difference −0.7 % 95% CI −0.1 to −1.3Authors' conclusion
In people with T2D, ECP45 for 7 weeks improved glycemic control when compared to ECP30 and a SHAM control group.
Study context
- Population
- People with T2D
- Participants
- 50 people
- Comparison
- ECP 45-min vs ECP 30-min sessions vs SHAM
- Primary endpoint
- Change in HbA1c
- Follow-up
- 7 weeks
Methodological detailssham-controlled, 3-arm
- Sham-controlled
- 3-arm
Primary result
As reported in the abstract
Mean difference
−0.7 %
95% CI −0.1 to −1.3
Change by group
ECP45
−0.8
mean · SD 0.8 · %
ECP30
−0.2
mean · SD 0.5 · %
SHAM
−0.1
mean · SD 0.9 · %
Further findings
HbA1c 7 weeks after intervention ended
Mmol/mol ECP45 53 ± 26 · ECP30 60 ± 16 · SHAM 60 ± 10
HbA1c 7 weeks after intervention ended
- HbA1c in ECP45 remained lower
Original publication
Efficacy of two doses of external counterpulsation (ECP) on glycemic control in people with type 2 diabetes mellitus: A randomized SHAM-controlled trial. Diabetes Res Clin Pract. Published 10 May 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →